His study on Risk analysis (engineering) is often connected to Social psychology as part of broader study in Cost effectiveness. His research is interdisciplinary, bridging the disciplines of Cost effectiveness and Risk analysis (engineering). In the subject of general Pharmacoeconomics, his work in Intensive care medicine is often linked to Management science, thereby combining diverse domains of study. His research on Intensive care medicine often connects related topics like Pharmacoeconomics. His research in the fields of Environmental health overlaps with other disciplines such as Psychiatry. His Environmental health study frequently links to related topics such as Population. He undertakes interdisciplinary study in the fields of Health care and Family medicine through his research. Alan Haycox conducted interdisciplinary study in his works that combined Family medicine and Health care. His studies link MEDLINE with Law.
His studies examine the connections between Economic growth and genetics, as well as such issues in Health care, with regards to Law. Alan Haycox regularly ties together related areas like Health care in his Law studies. His Internal medicine study frequently draws connections to other fields, such as Randomized controlled trial. He combines Nursing and Family medicine in his research. While working on this project, he studies both Family medicine and Nursing. He performs multidisciplinary study in Public health and Health economics in his work. With his scientific publications, his incorporates both Health economics and Public health. He performs multidisciplinary study in Surgery and Internal medicine in his work. His research is interdisciplinary, bridging the disciplines of Population and Environmental health.
Alan Haycox is conducting research in Reimbursement, Essential medicines and Health technology as part of his Health care study. His Reimbursement study typically links adjacent topics like Economic growth. Many of his studies on Economic growth apply to Low and middle income countries as well. He integrates Essential medicines with Health care in his research. As part of his research on Developing country, studies on Access to medicines and Low and middle income countries are part of the effort. His study connects Interquartile range and Surgery. As part of his studies on Interquartile range, he often connects relevant areas like Internal medicine. Alan Haycox conducts interdisciplinary study in the fields of Internal medicine and Emergency medicine through his research. While working on this project, Alan Haycox studies both Emergency medicine and Surgery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Systematic review of cost effectiveness studies of telemedicine interventions.
Pamela S Whitten;Frances S Mair;Alan Haycox;Carl R May.
Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers.
Jakub Adamski;Brian Godman;Brian Godman;Brian Godman;Gabriella Ofierska-Sujkowska;Bogusława Osińska.
The impact of non‐compliance on the cost‐effectiveness of pharmaceuticals: a review of the literature
Dyfrig A. Hughes;Adrian Bagust;Alan Haycox;Tom Walley.
Health Economics (2001)
A systematic review of the effectiveness and cost-effectiveness of neuroimaging assessments used to visualise the seizure focus in people with refractory epilepsy being considered for surgery
Penny F Whiting;R Gupta;J Burch;R E Mujica Mota.
Health Technology Assessment (2006)
Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance.
Brian Godman;Björn Wettermark;Mikael Hoffmann;Karolina Andersson.
Coronary artery stents: a rapid systematic review and economic evaluation
R Hill;A Bagust;A Bakhai;R Dickson.
Health Technology Assessment (2004)
Ongoing pharmaceutical reforms in France: implications for key stakeholder groups.
Catherine Sermet;Veronique Andrieu;Brian Godman;Brian Godman;Brian Godman;Eric Van Ganse.
Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation
Y Dündar;A Boland;J Strobl;S Dodd.
Health Technology Assessment (2004)
The Iranian Health Insurance System; Past Experiences, Present Challenges And Future Strategies
M Davari;A Haycox;T Walley.
Iranian Journal of Public Health (2012)
Recent national and regional drug reforms in Sweden: implications for pharmaceutical companies in Europe.
Björn Wettermark;Björn Wettermark;Brian Godman;Karolina Andersson;Lars L. Gustafsson;Lars L. Gustafsson.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: